Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|April 30, 2015
Economic Benefits of Chronic Care Management Programs
Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, talks about the economic benefits of Chronic Care Management programs.
Advertisement
Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, talks about the economic benefits of Chronic Care Management programs.
This video was recorded at APhA's Annual Meeting and Exposition in March 2015.
Advertisement
Related to this article
Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Dapagliflozin in Heart Failure: Congestion Isn't the Gatekeeper
2
New Data Reshapes Nonstatin Lipid Therapy Choices
3
Ambulatory Pharmacists Convene in Boston at NEIAP's 2026 Annual Forum
4
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
5